Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 2
1951 1
1952 2
1953 6
1954 9
1955 9
1956 10
1957 4
1958 3
1959 13
1960 5
1961 18
1962 17
1963 24
1964 23
1965 28
1966 30
1967 34
1968 36
1969 52
1970 39
1971 51
1972 54
1973 40
1974 62
1975 60
1976 54
1977 81
1978 83
1979 92
1980 83
1981 96
1982 112
1983 102
1984 138
1985 157
1986 169
1987 156
1988 175
1989 189
1990 196
1991 193
1992 205
1993 227
1994 275
1995 279
1996 260
1997 257
1998 300
1999 305
2000 347
2001 381
2002 376
2003 405
2004 398
2005 416
2006 401
2007 409
2008 460
2009 472
2010 538
2011 545
2012 619
2013 612
2014 612
2015 691
2016 712
2017 682
2018 673
2019 658
2020 695
2021 743
2022 67
Text availability
Article attribute
Article type
Publication date

Search Results

15,389 results
Results by year
Filters applied: . Clear all
Page 1
Tracing the origin of hair follicle stem cells.
Morita R, Sanzen N, Sasaki H, Hayashi T, Umeda M, Yoshimura M, Yamamoto T, Shibata T, Abe T, Kiyonari H, Furuta Y, Nikaido I, Fujiwara H. Morita R, et al. Among authors: yamamoto t. Nature. 2021 Jun;594(7864):547-552. doi: 10.1038/s41586-021-03638-5. Epub 2021 Jun 9. Nature. 2021. PMID: 34108685
Capturing human trophoblast development with naive pluripotent stem cells in vitro.
Io S, Kabata M, Iemura Y, Semi K, Morone N, Minagawa A, Wang B, Okamoto I, Nakamura T, Kojima Y, Iwatani C, Tsuchiya H, Kaswandy B, Kondoh E, Kaneko S, Woltjen K, Saitou M, Yamamoto T, Mandai M, Takashima Y. Io S, et al. Among authors: yamamoto t. Cell Stem Cell. 2021 Jun 3;28(6):1023-1039.e13. doi: 10.1016/j.stem.2021.03.013. Epub 2021 Apr 7. Cell Stem Cell. 2021. PMID: 33831365
Genetic and chemical inhibition of IRF5 suppresses pre-existing mouse lupus-like disease.
Ban T, Kikuchi M, Sato GR, Manabe A, Tagata N, Harita K, Nishiyama A, Nishimura K, Yoshimi R, Kirino Y, Yanai H, Matsumoto Y, Suzuki S, Hihara H, Ito M, Tsukahara K, Yoshimatsu K, Yamamoto T, Taniguchi T, Nakajima H, Ito S, Tamura T. Ban T, et al. Among authors: yamamoto t. Nat Commun. 2021 Jul 19;12(1):4379. doi: 10.1038/s41467-021-24609-4. Nat Commun. 2021. PMID: 34282144 Free PMC article.
Discontinuation of infliximab in patients with ulcerative colitis in remission (HAYABUSA): a multicentre, open-label, randomised controlled trial.
Kobayashi T, Motoya S, Nakamura S, Yamamoto T, Nagahori M, Tanaka S, Hisamatsu T, Hirai F, Nakase H, Watanabe K, Matsumoto T, Tanaka M, Abe T, Suzuki Y, Watanabe M, Hibi T; HAYABUSA Study Group. Kobayashi T, et al. Among authors: yamamoto t. Lancet Gastroenterol Hepatol. 2021 Jun;6(6):429-437. doi: 10.1016/S2468-1253(21)00062-5. Epub 2021 Apr 20. Lancet Gastroenterol Hepatol. 2021. PMID: 33887262 Clinical Trial.
Molecular biology of autoinflammatory diseases.
Masumoto J, Zhou W, Morikawa S, Hosokawa S, Taguchi H, Yamamoto T, Kurata M, Kaneko N. Masumoto J, et al. Among authors: yamamoto t. Inflamm Regen. 2021 Oct 11;41(1):33. doi: 10.1186/s41232-021-00181-8. Inflamm Regen. 2021. PMID: 34635190 Free PMC article. Review.
Expanding the KIF4A-associated phenotype.
Kalantari S, Carlston C, Alsaleh N, Abdel-Salam GMH, Alkuraya F, Kato M, Matsumoto N, Miyatake S, Yamamoto T, Fares-Taie L, Rozet JM, Chassaing N, Vincent-Delorme C, Kang-Bellin A, McWalter K, Bupp C, Palen E, Wagner MD, Niceta M, Cesario C, Milone R, Kaplan J, Wadman E, Dobyns WB, Filges I. Kalantari S, et al. Among authors: yamamoto t. Am J Med Genet A. 2021 Dec;185(12):3728-3739. doi: 10.1002/ajmg.a.62443. Epub 2021 Aug 3. Am J Med Genet A. 2021. PMID: 34346154
Skin metastasis of malignant mesothelioma.
Mori T, Yamamoto T. Mori T, et al. Among authors: yamamoto t. An Bras Dermatol. 2021 Sep-Oct;96(5):642-643. doi: 10.1016/j.abd.2020.07.020. Epub 2021 Jul 23. An Bras Dermatol. 2021. PMID: 34304935 Free PMC article. No abstract available.
15,389 results
You have reached the last available page of results. Please see the User Guide for more information.